PFE news

Latest 20 stories · newest Nov 4, 2026

PFE
Nasdaq Jumps Over 200 Points as Chip Stocks Gain: Fear & Greed Index Remains in ‘Extreme Fear’ Zone
PFE
Stock Market: Will S&P 500 Open Up or Down Today?
PFE
Pfizer, Apple And 3 Stocks To Watch Heading Into Tuesday
PFE
AMD, Shopify On Deck Tuesday As AI Spending, Merchant Growth Face Test
PFE
AMD Could Swing $90.7 Billion After Earnings
PFE
Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'
PFE
Reported Earlier: 'Cancer Vaccines Are the N.I.H's Next Big Bet' - The New York Times
PFE
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
PFE
Vaxcyte Stock Hits New 52-Week High - Here’s Why
PFE
Merck Advances European Regulatory Approval For Keytruda Combination In Bladder Cancer
PFE
Moderna Stock Cools Off After-Hours, Following Massive 177% Cancer Vaccine Rally — Merck, Pfizer and BioNTech Among mRNA Names Trending Tonight
PFE
Pfizer Stock Rises Wednesday: What's Going On?
PFE
Merck Just Raised the Stakes for Pfizer's Cancer Vaccine Ambitions
PFE
4 Health Care Stocks With Whale Alerts In Today’s Session
PFE
4 Health Care Stocks With Whale Alerts In Today’s Session
PFE
Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All Children
PFE
U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
PFE
Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'
PFE
Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone
PFE
Pfizer Q2 2026 revenue up 1%; raises 2026 guidance

Pfizer achieved operational revenue growth in Q2 2026 and raised its full-year 2026 revenue guidance, demonstrating continued business strength despite a reported diluted loss per share due to non-cash impairments.

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same PFE feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/PFE/newsSTART FREE